AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17063641
Drug: Thyme-ivy combination
RxNorm normalized name: THYME
DrugBank: Thyme (DB10983)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyme-ivy combination syrup and Placebo syrup
Trial: 12953167
Drug: Low-dose radioiodine-131
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose radioiodine-131 (131I) treatment (141 +/- 85 MBq)
Trial: 10782840
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose rhGH (12 IU/m2/week)
Trial: 10782840
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose rhGH (24 IU/m2/week)
Trial: 9324342
Drug: CVPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVPP chemotherapy (3 cycles)
Trial: 9324342
Drug: CVPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVPP chemotherapy (6 cycles)
Trial: 9324342
Drug: CVPP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVPP chemotherapy (6 cycles) + Radiotherapy (RT)
Trial: 9324342
Drug: AOPE chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AOPE chemotherapy (6 cycles) + Radiotherapy (RT)
Trial: 9324342
Drug: CCOPP/CAPTe chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCOPP/CAPTe chemotherapy (6 cycles)
Trial: 8223808
Drug: Acetaminophen administered
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen administered at regular 4h intervals (group 1)
Trial: 8223808
Drug: Sporadic usage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sporadic usage of acetaminophen contingent upon a body temperature above 37.9 degrees C (group 2)
Trial: 8223808
Drug: Sporadic usage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sporadic usage of acetaminophen (group 2)
Trial: 3950253
Drug: Terbutaline (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (0.25 mg per puff)
Trial: 30075954
Drug: Oestradiol 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestradiol 1.5 mg/day for 6 months
Trial: 30075954
Drug: Testosterone 50
RxNorm normalized name: testosterone 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 50 mg/day for 6 months
Trial: 24909487
Drug: Magnesium oxide
RxNorm normalized name: Magnesium Oxide
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium oxide 450 mg up to three times daily
Trial: 18316791
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment arms
Trial: 17220631
Drug: Oral orlistat
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral orlistat
Trial: 8784758
Drug: Aspirin (1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1.3 g) before running
Trial: 8784758
Drug: Aspirin (1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1.3 g) before rest
Trial: 7930385
Drug: Normal subjects
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal subjects rendered mildly hyperglycemic by a 24-h glucose infusion (1 mg/kg/min for NDT and 2 mg/kg/min for IGT)
Trial: 21838913
Drug: Selenium micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium micronutrient supplement
Trial: 15294856
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (screening and treatment for infection)
Trial: 9602986
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg daily, at night)
Trial: 9602986
Drug: Sucralfate (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralfate (2 g twice daily)
Trial: 2403809
Drug: Surgery and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery and steroids
Trial: 359215
Drug: Trimazosin 100
RxNorm normalized name: trimazosin
DrugBank: Trimazosin (DB09206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimazosin 100 to 300 mg
Trial: 26581750
Drug: High-dose esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose esomeprazole (80 mg + 8 mg/h)
Trial: 26581750
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 mg + 60 mg/h)
Trial: 24232362
Drug: Structured exercise
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured exercise program (weekly supervised gym sessions of stationary cycling and resistance exercises, and a twice weekly independent home-based walking program)
Trial: 19274317
Drug: Weekly doses
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly doses of 25 mg of elemental iron administered at home
Trial: 19274317
Drug: Weekly doses
RxNorm normalized name: selinexor
DrugBank: Selinexor (DB11942)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly doses of 25 mg of elemental iron administered in healthcare clinic
Trial: 14535968
Drug: Hyperglycaemia (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycaemia (15 mmol L(‐1))
Trial: 2029860
Drug: Tramadol 150
RxNorm normalized name: traMADol 150 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 150 mg
Trial: 2029860
Drug: Tramadol 300
RxNorm normalized name: TRAMADOL 300MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 300 mg
Trial: 9589267
Drug: Morphine 15
RxNorm normalized name: morphine 15 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 15 mg
Trial: 3829579
Drug: Morphine 30
RxNorm normalized name: ethylmorphine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 30 mg
Trial: 27812636
Drug: Gel pillow
RxNorm normalized name: Willow bark
DrugBank: Willow bark (DB14691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel pillow with side cutouts
Trial: 17379047
Drug: VAL/HCTZ 320/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAL/HCTZ 320/25 mg
Trial: 10190880
Drug: Tyramine administration
RxNorm normalized name: tyramine
DrugBank: Tyramine (DB08841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyramine administration
Trial: 15305962
Drug: Isoproterenol administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol administration
Trial: 27164015
Drug: Phenylephrine administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine administration
Trial: 11422018
Drug: Bisoprolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (5 mg)
Trial: 11527135
Drug: Atenolol and
RxNorm normalized name: atenolol and thiazides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol and Bisoprolol (both beta1-selective beta-blockers)
Trial: 6127907
Drug: Anti-anxiety drugs
RxNorm normalized name: INVESTIGATIONAL ANTI-ANXIETY DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-anxiety drugs (including clorazepate and diazepam)
Trial: 30588277
Drug: Telerehabilitation (TR)
RxNorm normalized name: hyoscyamine sulfate Extended Release Oral Tablet [Hyoscyamine TR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telerehabilitation (TR) treatment
Trial: 30588277
Drug: In-person (IP)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: In-person (IP) treatment
Trial: 27771799
Drug: Salbutamol (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (1000 µg)
Trial: 24253140
Drug: Balanced solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced solution of 6% hydroxyethyl starch (Plasma Volume Redibag)
Trial: 15704613
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 20 mg rabeprazole
Trial: 15704613
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of 20 mg rabeprazole
Trial: 15704613
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (oral and intravenous)
Trial: 1780994
Drug: Chloroquine phosphate
RxNorm normalized name: Chloroquine Phosphate
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine phosphate 2500 mg over 3 days
Trial: 1780994
Drug: Chloroquine prophylaxis
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine prophylaxis 500 mg weekly for 27 weeks
Trial: 1780994
Drug: Chloroquine prophylaxis
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine prophylaxis 500 mg weekly for 27 weeks after nodulectomy and acute malaria treatment
Trial: 11928797
Drug: Surgical and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical and chemotherapeutic treatment
Trial: 31926827
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist luteal support 0.1 mg SC every other day, starting on day 3 post egg retrieval
Trial: 31926827
Drug: 80 Âµg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 Âµg recombinant hCG (Ovitrelle, Merck Serono SA) as control, single dose on day 3 post-egg retrieval
Trial: 25899956
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg orally twice a day for 4 days (10 doses total)
Trial: 24306214
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein diet (NPD) - 1.2 g protein ⋅ kg body weight(‐1) ⋅ d(‐1)
Trial: 24306214
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein diet (LPD) - 0.1 g protein ⋅ kg body weight(‐1) ⋅ d(‐1)
Trial: 11524347
Drug: Parecoxib Sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib Sodium 20 mg IV
Trial: 11524347
Drug: Parecoxib Sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib Sodium 40 mg IV
Trial: 11524347
Drug: Parecoxib Sodium
RxNorm normalized name: parecoxib sodium
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib Sodium 80 mg IV
Trial: 9930595
Drug: Loratadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine (10 mg daily p.o.)
Trial: 8039123
Drug: Ocular ice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ocular ice pack therapy
Trial: 28291957
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (40IU)
Trial: 23345639
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 to 600 mg/d
Trial: 18066566
Drug: RAL (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RAL (60 mg daily and continuously)
Trial: 18066566
Drug: HRT (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (2 mg estradiol valerat + 2 mg dienogest, continuously)
Trial: 1735849
Drug: Synthetic surfactant
RxNorm normalized name: Synthetic surfactant comprised of DPPC, POPG Na, synthetic SP-C analogue and synthetic SP-B analogue
DrugBank: CHF5633 (DB18696)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic surfactant (Exosurf Neonatal) 5 ml/kg
Trial: 1993961
Drug: Air (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air (control group) 5 ml/kg
Trial: 6501237
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg yohimbine hydrochloride
Trial: 6501237
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg yohimbine hydrochloride
Trial: 27055606
Drug: Jet injection
RxNorm normalized name: Jet Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet injection of lidocaine
Trial: 22503057
Drug: Drug-eluting balloon
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting balloon (DEB) plus bare-metal stent (BMS)
Trial: 11115952
Drug: Poor effort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Poor effort to take medication
Trial: 23791061
Drug: HTK solution
RxNorm normalized name: Custodial HTK Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTK solution
Trial: 1352564
Drug: EuroCollins solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EuroCollins solution
Trial: 4030486
Drug: Hyaluronidase added
RxNorm normalized name: Hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hyaluronidase added to retrobulbar anesthetic injection
Trial: 4030486
Drug: Topical indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical indomethacin before surgery and for nine months postoperatively
Trial: 29083477
Drug: Intranasal birch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal birch pollen allergen Bet v 1
Trial: 29083477
Drug: Intranasal omalizumab
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal omalizumab
Trial: 29083477
Drug: Subcutaneous omalizumab
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous omalizumab
Trial: 26906034
Drug: Anakinra 100
RxNorm normalized name: ANAKINRA 100MG INJ,SYRINGE,1ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra 100 mg twice daily for 3 days followed by once daily for 11 days
Trial: 20556260
Drug: Mucosa-supported implant-retained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucosa-supported implant-retained overdenture (OD) with an ovoid bar (two implants; design 1)
Trial: 20556260
Drug: Mucosa-supported implant-retained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mucosa-supported implant-retained overdenture (OD) with multiple ovoid bars (four implants; design 2)
Trial: 20556260
Drug: Rigid implant-supported
RxNorm normalized name: Pinus rigida pollen
DrugBank: Pinus rigida pollen (DB10896)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rigid implant-supported prosthesis (ISP) with a milled bar (design 3)
Trial: 18391103
Drug: eGFR <40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR <40 mL/min
Trial: 18391103
Drug: eGFR 40
RxNorm normalized name: Egfr t790m inhibitor pf-06747775
DrugBank: Mavelertinib (DB16228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR 40 to 60 mL/min
Trial: 18391103
Drug: eGFR >60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR >60 mL/min
Trial: 15826311
Drug: Estrogen‐progestogen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen‐progestogen therapy
Trial: 15826311
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or no drugs
Trial: 12516831
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EMD and GTR using a collagen membrane
Trial: 12516831
Drug: GTR monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GTR monotherapy
Trial: 12516831
Drug: EMD monotherapy
RxNorm normalized name: Emdisterone
DrugBank: Drostanolone propionate (DB14655)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMD monotherapy
Trial: 1743444
Drug: High-dose dipyridamole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dipyridamole echocardiography test (DET: 2D-echo monitoring during dipyridamole infusion up to 0.84 mg/kg over 10 minutes)
Trial: 1743444
Drug: High-dose dipyridamole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dipyridamole echocardiography test (DET)
Trial: 9603590
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg bromazepam
Trial: 31050201
Drug: Prucalopride 2
RxNorm normalized name: prucalopride 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prucalopride 2 mg plus 45 mL NaP (P-NaP)
Trial: 31050201
Drug: 90 mL
RxNorm normalized name: 190 ML Infugem 10 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mL NaP in two split doses (90-NaP)
Trial: 27886382
Drug: Cucumis sativus
RxNorm normalized name: CUCUMIS SATIVUS LEAF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cucumis sativus seed extract (500 mg daily for 6 weeks)
Trial: 27886382
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one capsule daily for 6 weeks)
Trial: 19553407
Drug: NB‐UVB plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NB‐UVB plus oral vitamin E (group A)
Trial: 17684214
Drug: Glutamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (0.25 mg/kg body weight) administered orally twice daily for 5 months
Trial: 17684214
Drug: Placebo (isonitrogenous,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (isonitrogenous, isoenergetic mix of nonessential amino acids) administered orally twice daily for 5 months
Trial: 9118772
Drug: Troglitazone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone (400 mg QAM)
Trial: 3520622
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose insulin infusion clamp study (8mU/M2/min)
Trial: 3520622
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose insulin infusion clamp study (40mU/M2/min)
Trial: 22650119
Drug: Acupoint thread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint thread embedding combined with western medicine routine therapy
Trial: 22650119
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy group (western medicine routine therapy)
Trial: 22990319
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab (0.3 or 0.5 mg)
Trial: 9695060
Drug: Workers with
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Workers with urine mercury concentration between 51 and 150 micrograms l-1
Trial: 9695060
Drug: Workers with
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Workers with urine mercury concentrations above 150 micrograms l-1
Trial: 8083550
Drug: Puvasol in
RxNorm normalized name: docusate sodium / sennosides, USP Oral Tablet [Purgasol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Puvasol in combination with topical tar therapy
Trial: 23650416
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg daily plus entinostat 5 mg once per week (EE)
Trial: 19359813
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day of bepridil
Trial: 19359813
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day of bepridil
Trial: 16371522
Drug: Self-hypnotic relaxation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-hypnotic relaxation
Trial: 12166555
Drug: Montelukast (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (5 mg)
Trial: 11062381
Drug: Neoadjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neoadjuvant hormonal therapy (NHT) using an LHRH analog (goserelin) plus flutamide for a period of 3 months
Trial: 19240996
Drug: Neoadjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neoadjuvant hormonal therapy (NHT)
Trial: 9066598
Drug: EPI alone
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPI alone (120 mg/m2 x 3)
Trial: 9066598
Drug: EPI +
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPI + ICRF‐187 (1000 mg/m2)
Trial: 9066598
Drug: EPI +
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPI + C0Q10 (50 mg/day)
Trial: 8373608
Drug: Thiopental sodium
RxNorm normalized name: Thiopental Sodium
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopental sodium (4 mg/kg) and succinylcholine (1 mg/kg)
Trial: 28230639
Drug: Early discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early discontinuation of CNI therapy after introduction of an mTOR inhibitor